Key terms

About TCON

TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, and ophthalmic and fibrotic diseases. Its products include TRC105, an anti-endoglin antibody for the treatment of solid tumor types, TRC205 created for the treatment of fibrotic diseases, and TRC102, a small molecule that is in clinical development made for lung cancer and glioblastoma. The company was founded in October 2004 and is headquartered in San Diego, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest TCON news

Apr 12 4:54pm ET Tracon Pharmaceuticals files to sell common stock, warrants, no amount given by TipRanks Apr 08 9:14am ET Tracon Pharmaceuticals announces 1-for-20 reverse stock split by TipRanks Apr 03 12:25pm ET Buy Rating Affirmed for TRACON Pharmaceuticals Amid Promising Envafolimab Trial Outlook by TipRanks Apr 03 12:15pm ET Tracon Pharmaceuticals price target lowered to $3 from $6 at H.C. Wainwright by TipRanks Apr 03 8:05am ET Tracon says IDMC reccommends ENVASARC Phase 2 trial continue ‘as planned’ by TipRanks Mar 25 8:31am ET Two new option listings and option delistings on March 25th by TipRanks Mar 15 11:32am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Mar 13 8:46am ET JonesTrading Reaffirms Their Hold Rating on TRACON Pharmaceuticals (TCON) by TipRanks Mar 11 11:13am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Mar 08 10:46am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Mar 07 10:35am ET Buy Rating for TRACON Pharmaceuticals on Strong Financials and Promising Clinical Trials by TipRanks Mar 07 10:29am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Mar 06 6:05am ET Tracon Pharmaceuticals price target lowered to $6 from $7 at H.C. Wainwright by TipRanks Mar 05 4:13pm ET Tracon Pharmaceuticals reports Q4 EPS 1c, consensus (8c) by TipRanks Mar 05 4:13pm ET Tracon Pharmaceuticals reports Q4 EPS 1c, consensus (8c) by TipRanks

No recent news articles are available for TCON

No recent press releases are available for TCON

TCON Financials

1-year income & revenue

Key terms

TCON Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

TCON Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming
Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images
Samuel Corum/Bloomberg/Getty Images
Geopolitical strife is roiling Wall Street. Here’s what investors are watching
Donald Trump might no longer own a majority of TMTG after a new public share offering.
Joe Raedle/Getty Images
Trump stock tanks after announcing massive share sale
1040 US Individual Income Tax Return Form
Nora Carol Photography/Moment RF/Getty Images
Three ways investors can minimize their tax payments